Peptides for Gut Health: Where Local Action Actually Makes Sense

The gut is the one context where a peptide’s poor absorption is an advantage. Everywhere else, digestion is the obstacle. Here, the target tissue is the one the compound is passing through.

That makes route unusually important in this area, and it is the thread connecting the three compounds most often discussed.

The three candidates

They differ substantially in how far each has been tested, and larazotide is the outlier — it got much further than the other two.

Larazotide got the furthest

Larazotide reached phase 3 trials for coeliac disease as an adjunct to a gluten-free diet, and that programme did not produce an approved product.

That result is more informative than the absence of data around the other two. A compound tested rigorously and found wanting is in a different position from one never tested at all. See the larazotide guide.

BPC-157 and the gut

BPC-157 derives from a sequence found in gastric juice, and much of its preclinical literature concerns gastrointestinal healing — which is where the compound started before attention moved to tendons and ligaments.

The gut work is the oldest and largest part of that literature. It is also, like the rest of it, almost entirely rodent. The BPC-157 guide covers why converting those studies to human figures is not simple arithmetic.

KPV and inflammation

KPV is the three-amino-acid tail of alpha-MSH, retaining anti-inflammatory associations without pigmentation activity. Much of its research concerns intestinal inflammation, often with local delivery. See the KPV guide.

Why route decides the question

On "leaky gut"

Intestinal permeability is real and measurable, and it is studied seriously in coeliac disease and inflammatory bowel disease. The popular term covers a much broader and vaguer set of claims than the measurable phenomenon supports.

Larazotide is a genuine permeability-modulating compound, which is why it gets pulled into that conversation. The specific version of the claim is narrow; the popular version is not.

Frequently asked questions

Is oral or injected better for gut peptides?

It depends on where the compound is meant to act. For luminal targets, oral delivery is the point. For systemic action, injection.

Does BPC-157 heal the gut?

Rodent studies report gastrointestinal healing effects. No human trial establishes that, or a dose.

What about collagen peptides?

Those are a different category — food-derived protein fragments sold as supplements, not the synthetic research compounds discussed here.